Antiretroviral News and Research

RSS

HIV drug resistance spreading in China, researcher says

As HIV spreads beyond high-risk groups into China's general population, drug-resistant strains of the virus also are appearing in parts of the country, Chen Zhiwei of the AIDS Institute in Hong Kong said recently, Reuters reports.

13 Oct 2008

Drug companies plan to invest in HIV/AIDS drug development, improve access, U.N. Secretary-General says

United Nations Secretary-General Ban Ki-moon on Thursday said that many large pharmaceutical companies -- including Abbott Labs, Boehringer Ingelheim, GlaxoSmithKline and Pfizer -- plan to increase their efforts to develop HIV/AIDS drugs and diagnostics for impoverished regions, Reuters reports.

13 Oct 2008

Ukraine Parliament introduces bill to increase HIV prevention, treatment efforts

Ukraine's Parliament recently approved a bill that would establish a national program to increase HIV/AIDS prevention and treatment efforts in the country, Ukrainian News reports.

5 Oct 2008

Spiritual healing threatening adherence to antiretrovirals in Uganda, official says

Unverified spiritual healing promoted by some churches throughout Uganda is threatening HIV-positive patients' adherence to antiretroviral drugs, Robert Ochai, executive director of The AIDS Support Organisation, said recently during the organization's 17th annual general meeting, Uganda's Monitor reports.

5 Oct 2008

Newspapers examine efforts, reaction to easing ban on HIV-positive visitors to U.S.

Some HIV/AIDS advocates are "being cautious with their optimism" regarding new immigration rules for HIV-positive visitors as well as HHS efforts to remove HIV from the list of diseases barring entry into the U.S., the San Francisco Chronicle reports (Fulbright, San Francisco Chronicle, 10/2).

5 Oct 2008

Studies examine ability of antiretroviral Maraviroc to control HIV viral loads

According to two studies sponsored by drugmaker Pfizer and published in the New England Journal of Medicine on Wednesday, the antiretroviral drug maraviroc, which is sold as Selzentry by Pfizer, might help control viral loads among HIV-positive people who have shown resistance to other treatments, Reuters reports.

5 Oct 2008

Health workers cannot refuse to provide treatment to HIV-positive people, India's Supreme Court rules

A panel of India's Supreme Court on Wednesday approved instructions from the country's Centre Party that health care workers in all government and private hospitals cannot refuse medical treatment to people living with HIV/AIDS, The Hindu reports.

5 Oct 2008

CDC says 1.1 million people living with HIV

CDC on Friday in its Morbidity and Mortality Weekly Report released updated estimates of HIV prevalence in the U.S., saying that 1.1 million people were living with the virus at the end of 2006, Bloomberg reports.

5 Oct 2008

PEPFAR suspends funding for three Ranbaxy AIDS drugs banned by FDA

The President's Emergency Plan for AIDS Relief program has suspended funding for three antiretroviral drugs manufactured by Indian generic drugmaker Ranbaxy that were included in an importation ban imposed by FDA on Sept. 16, Bloomberg reports.

29 Sep 2008

Thai health experts call for review of prevention of mother-to-child HIV transmission program

Health experts in Thailand are calling for a review of the country's national program to prevent mother-to-child HIV transmission, which follows World Health Organization guidelines, the Bangkok Post reports.

24 Sep 2008

House members send letter to Condoleezza Rice requesting information on antiretrovirals supplied to PEPFAR by Ranbaxy

Rep. John Dingell (D-Mich.) and members of the House Committee on Energy and Commerce on Friday sent a letter to Secretary of State Condoleezza Rice requesting information about alleged safety problems with antiretrovirals manufactured by the Indian generic pharmaceutical company Ranbaxy and distributed through the President's Emergency Plan for AIDS Relief, the AP/International Herald Tribune reports (AP/International Herald Tribune, 9/19).

22 Sep 2008

Newsweek examines the effect of aging on people living with HIV/AIDS

Newsweek on Thursday examined the effects of aging on HIV-positive people older than age 50, who currently comprise the fastest-growing group of people living with HIV/AIDS in the U.S. From 1990 to 2005, the number of HIV cases among people older than 50 increased by more than 700%, according to local Department of Health studies.

22 Sep 2008

Supply shortages, poverty interrupt antiretroviral treatments in Swaziland

Health facilities in Swaziland are experiencing shortages in antiretroviral drugs and other medications despite insistence from the country's health department that the shortage has been resolved, IRIN/PlusNews reports.

22 Sep 2008

Brazil to produce generic version of Merck's antiretroviral Efavirenz

Brazilian Health Minister Jose Gomes Temporao on Wednesday said Brazil will begin producing a generic version of Merck's antiretroviral efavirenz, the AP/USA Today reports.

22 Sep 2008

China should provide medical care, compensation to HIV-positive blood donors, Piot says

UNAIDS Executive Director Peter Piot on Thursday encouraged the Chinese government to provide compensation and medical care to thousands of people who contracted HIV through the government-supported blood transfusions in the late 1990s and early 2000s, AFP/AsiaOne News reports.

22 Sep 2008

Mozambique's progress on HIV/AIDS insufficient, World Bank official says

Mozambique has made insufficient progress in efforts to address HIV/AIDS over the past year despite increased efforts to expand access to antiretroviral drugs, a World Bank official said on Wednesday at a meeting held in Maputo, Mozambique, to review the country's progress in implementing World Bank-financed projects over the last year, the Independent Online reports.

22 Sep 2008

Early antiretroviral treatment for people with HIV/TB coinfection could reduce mortality by half

People with HIV/tuberculosis coinfection who began antiretroviral treatment within six months of starting TB treatment had a 55% lower mortality rate than people with HIV/TB coinfection who did not begin antiretroviral therapy until after they had finished a six-month TB treatment course, according to a study conducted by researchers at the University of KwaZulu-Natal, Business Day reports (Kahn, Business Day, 9/18).

22 Sep 2008

Indian High Court forms committee to address HIV/AIDS in prisons

The high court in Mumbai, India, on Thursday formed a committee to create guidelines aimed at preventing the spread of HIV in prisons in response to the increasing spread of the virus among inmates, the Daily News & Analysis reports.

16 Sep 2008

Herpes drug Acyclovir could help control HIV

Acyclovir -- a low-cost, generic drug used to treat herpes -- also might help control HIV in people living with both viruses, according to a study published Wednesday in the journal ell Host and Microbe, Reuters reports.

15 Sep 2008

Irish Times examines HIV/AIDS efforts in Moldovan region

The Irish Times on Tuesday examined the efforts of a Medecins Sans Frontieres mission in Transdniestria -- an enclave in Moldova that supports Russia and declared its independence from Moldova in 1990 -- to improve its health care system and implement an HIV/AIDS center in light of the region's high prevalence of the disease, which is four times that of the national average

11 Sep 2008

Antiretroviral News and Research

HIV drug resistance spreading in China, researcher says

Drug companies plan to invest in HIV/AIDS drug development, improve access, U.N. Secretary-General says

Ukraine Parliament introduces bill to increase HIV prevention, treatment efforts

Spiritual healing threatening adherence to antiretrovirals in Uganda, official says

Newspapers examine efforts, reaction to easing ban on HIV-positive visitors to U.S.

Studies examine ability of antiretroviral Maraviroc to control HIV viral loads

Health workers cannot refuse to provide treatment to HIV-positive people, India's Supreme Court rules

CDC says 1.1 million people living with HIV

PEPFAR suspends funding for three Ranbaxy AIDS drugs banned by FDA

Thai health experts call for review of prevention of mother-to-child HIV transmission program

House members send letter to Condoleezza Rice requesting information on antiretrovirals supplied to PEPFAR by Ranbaxy

Newsweek examines the effect of aging on people living with HIV/AIDS

Supply shortages, poverty interrupt antiretroviral treatments in Swaziland

Brazil to produce generic version of Merck's antiretroviral Efavirenz

China should provide medical care, compensation to HIV-positive blood donors, Piot says

Mozambique's progress on HIV/AIDS insufficient, World Bank official says

Early antiretroviral treatment for people with HIV/TB coinfection could reduce mortality by half

Indian High Court forms committee to address HIV/AIDS in prisons

Herpes drug Acyclovir could help control HIV

Irish Times examines HIV/AIDS efforts in Moldovan region

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News